Suzuki, Yoko
Iwamoto, Takayuki
Uno, Maya
Hatono, Minami
Kajiwara, Yukiko
Takahashi, Yuko
Kochi, Mariko
Shien, Tadahiko
Kikawa, Yuichiro
Uemura, Yukari
Hagiwara, Yasuhiro
Yamamoto, Seiichiro
Taira, Naruto
Doihara, Hiroyoshi
Toyooka, Shinichi
Funding for this research was provided by:
Pfizer Japan
Article History
Received: 2 May 2023
Accepted: 25 June 2023
First Online: 8 July 2023
Declarations
:
: Tadahiko Shien, Yuichiro Kikawa, and Naruto Taira received an honorarium from Pfizer Inc.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Okayama University Hospital (Cohort one: Date 2019.5.28/No. 1907–038, Cohort two: Date 2019.11.29/No. 1907–042).
: This study involving human participants was in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Written informed consent was obtained from all participants in the study.
: The authors affirm that all patients provided informed consent for publication of all figures and tables.